| Dr Allen J Schneider, MD | |
|
209 Affirmed Dr, Havre De Grace, MD 21078-3166 | |
| (609) 610-2090 | |
| Not Available |
| Full Name | Dr Allen J Schneider |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 209 Affirmed Dr, Havre De Grace, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1477536597 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 25MA03007300 (New Jersey) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Allen J Schneider, MD 209 Affirmed Dr, Havre De Grace, MD 21078-3166 Ph: (609) 610-2090 | Dr Allen J Schneider, MD 209 Affirmed Dr, Havre De Grace, MD 21078-3166 Ph: (609) 610-2090 |
News Archive
A new technique for assessing core stability or "lumbopelvic control" in the muscles of the hips, pelvis, and torso predicts on-field performance in minor-league baseball pitchers, according to a study in the August issue of The Journal of Strength and Conditioning Research, official research journal of the National Strength and Conditioning Association.
A new network dedicated to advancing research and therapies for stroke is forming in Chicago thanks to $2 million in grants from the National Institutes of Health. The Chicago Stroke Trials Consortium is a partnership among Northwestern Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, John H. Stroger Jr. Hospital, Loyola University Medical Center, Rehabilitation Institute of Chicago, Rush University Medical Center, and University of Chicago Medicine that will build an infrastructure to support clinical trials for stroke prevention, treatment and recovery. Northwestern University will be the regional coordinating center for the consortium and administer the project over the next five years.
Exiqon A/S, today announced that it has granted a non-exclusive license to BD to use Exiqon's proprietary locked nucleic acids technology in defined products for infectious disease diagnostics.
Researchers at University of California San Diego School of Medicine and Moores Cancer Center have identified RNA-based biomarkers that distinguish between normal, aging hematopoietic stem cells and leukemia stem cells associated with secondary acute myeloid leukemia (sAML), a particularly problematic disease that typically afflicts older patients who have often already experienced a bout with cancer.
Patrick MacDonald has dedicated much of his life to diabetes research. It's a job he knows is far too large and complex for any one person, but with his latest publication, he knows his work is playing a part.
› Verified 3 days ago
Dr. Marianne Fotiadis Fridberg, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 510 Revolution St, Havre De Grace, MD 21078 Phone: 410-939-5330 Fax: 410-939-6204 |